Darko Antić

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna et al. · Blood · 2020 · 318 citations · Full text

Pharmacy, Health Sciences, Internal Medicine +3

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Livio Pagano, Jon Salmanton‐García, Francesco Marchesi et al. · Journal of Hematology & Oncology · 2021 · 318 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

Andreas Agathangelidis, Anastasia Chatzidimitriou, Katerina Gemenetzi et al. · Blood · 2020 · 129 citations · Full text

Social Sciences, Oncology, Clinical Classification Systems +12

Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?

Darko Antić, Ivo Elezović, Nataša Milić et al. · Biomedicine & Pharmacotherapy · 2012 · 103 citations

Medicine, Oncology, Immunotherapy +3

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14